NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/04/2024
Back to search
Official data from USPTO
MUCINEX CHILDREN'S
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
10/04/2024
Trademark type
Combined
Nice classes
5
Filing date
11/16/2017
Registration date
03/05/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2024
Last transaction
10/04/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/31/2018
First use in commerce
08/31/2018
Drawing code
3
Owner type
16
Owner location
PARSIPPANY, NJ
Examiner
RICHARDSON, JENNIFER
Current location
Historical data usage
Mark description
The mark consists of rectangle with two cut corners on the top and a curved bottom, with a gray border, containing the stylized word "MUCINEX" appearing in blue on a white background, above the stylized word "CHILDREN'S" on a blue background, with the letter "C" in blue, the letter "H" in orange, the letter "I" in yellow, the letter "L" in green, the letter "D" in pink, the letter "R" in blue, the letter "E" in yellow, the letter "N" in green, the apostrophe in orange, and the letter "S" in pink.
Holders and representatives
Holders
RB HEALTH (US) LLC
Reckitt Benckiser LLC
Representatives
Mark Lerner, Esq. SATTERLEE STEPHENS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparationspharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds
Publications
History of USPTO decisions and trademark events.
33 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/04/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/30/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
09/30/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2024
E815
TEAS SECTION 8 & 15 RECEIVED
03/27/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/30/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/29/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/12/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/12/2019
IUAF
USE AMENDMENT FILED
12/11/2018
EISU
TEAS STATEMENT OF USE RECEIVED
12/11/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/06/2018
EX1G
SOU EXTENSION 1 GRANTED
12/04/2018
EXT1
SOU EXTENSION 1 FILED
12/04/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/04/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/21/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/10/2018
PUBO
PUBLISHED FOR OPPOSITION
04/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/21/2018
ALIE
ASSIGNED TO LIE
03/05/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
02/23/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/23/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
02/23/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/23/2018
DOCK
ASSIGNED TO EXAMINER
02/16/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/30/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/29/2017
NWAP
NEW APPLICATION ENTERED
11/20/2017
Continuous trademark protection
Get notified about every new filing that threatens MUCINEX CHILDREN'S or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.